- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03213470
Prospective Observation for Serial Changes in Acute Intracranial Artery Dissection Using HR-MRI
December 18, 2019 updated by: Seung Chai Jung, Asan Medical Center
Prospective Observation for Serial Changes in Acute Intracranial Artery Dissection Using High Resolution Vessel Wall Magnetic Resonance Imaging
Intracranial artery disease has been more detected with development of HR-MR.
HR-MR can depict vascular wall directly and give us more information beyond the pre-existing imaging modalities such as digital subtraction angiography, magnetic resonance angiography, computed tomography angiography.
Hence, HR-MR is considered to become promising imaging modality for intracranial artery disease and many studies have been published recently.
However, there was not enough to differentiate various intracranial artery disease such as atherosclerosis, dissection, moyamoya disease, vasculitis, reversible vasoconstriction syndrome.
In real clinical arena, intracranial artery disease is too difficult to diagnose and distinguish among the disease.
Of the disease, usefulness of HR-MR has been consistently published in the detection and diagnosis of intracranial artery dissection recently.
HR-MR seems to be the most important and reliable imaging method in intracranial artery dissection as of now.
Therefore, intracranial artery dissection is necessary to study using HR-MR.
Intracranial artery dissection is dynamic vascular pathology.
The geometric change is the most common among intracranial artery disease.
However, there was no report about the geometric change in HR-MR.
The investigators acquired retrospective data about the natural course of intracranial artery dissection in HR-MR and are preparing for publishing an article.
However, the data is not prospective and not intraindividual comparison.
Therefore, reliability is not enough to convince the natural course.
If the investigators got prospective and intraindividual data, definite natural course of intracranial artery dissection could be acquired and would be helpful to diagnose the dissection and differentiate from other vascular pathologies.
The longitudinal information from this study could guide us as the important map on the confusing HR-MR findings.
In addition, the previous retrospective study can be a stepping-stone to perform a prospective study, which can increase the success rate of the prospective study.
The protocols for imaging follow-up are as followed: initial (optional), 1 month, 3 month, 6 month (optional), 12 month
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Inclusion criteria:
- adults with equal to or greater than 18 year-old
- confirmed as acute intracranial artery dissection based on the clinical and radiological diagnoses
- informed consent
Exclusion criteria:
- contraindicated for MRI scanning and contrast media usage
- refuse the enrollment
Outcome measures
Serial follow-up with intraindividual comparisons and interstage comparisons
- Radiological features: intimal flap, double lumen, aneurysmal dilatation, intramural hematoma, luminal stenosis, contrast enhancement degree, diameters, length, wall thickness, eccentricity index
- Clinical features: mRS, NIHSS, drug
- Demographics
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 138-736
- Asan Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Informed consent
- Acute intracranial artery dissection
Exclusion Criteria:
- angioplasty, or stenting,
- contraindication for MR imaging,
- Hypersensitivity to gadolinium based contrast media,
- Pregnant or lactating women,
- Renal condition : eGFR < 60, 6) Patients unable and/or unwilling to comply with treatment or study instructions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Intracranial artery dissection
Patients with intracranial artery dissection who were diagnosed based on the clinical and radiological (including MRI) diagnoses at the symptom onset after Jan-01-2016
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prospective observation for serial changes in acute intracranial artery dissection using HR-MRI
Time Frame: The time interval from initial event to outcome measurement is 1 year.
|
Radiological findings of HR-MRI during the study period
|
The time interval from initial event to outcome measurement is 1 year.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Seung Chai Jung, Professor, Associate professor, Department of Radiology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
April 7, 2019
Study Completion (Actual)
April 7, 2019
Study Registration Dates
First Submitted
July 7, 2017
First Submitted That Met QC Criteria
July 7, 2017
First Posted (Actual)
July 11, 2017
Study Record Updates
Last Update Posted (Actual)
December 20, 2019
Last Update Submitted That Met QC Criteria
December 18, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ICD_01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dissection
-
Ohio State University Comprehensive Cancer CenterCompletedNeck Dissection | Radical Lymph Node DissectionUnited States
-
Centre Cardiologique du NordUniversita degli Studi di Genova; Henri Mondor University Hospital; Pitié-Salpêtrière...Enrolling by invitationAortic Valve Insufficiency | Aortic Diseases | Ascending Aortic Dissection | Aortic Arch | Aortic Root Dissection | Aortic Root Dilatation | Type A Aortic DissectionFrance
-
Stefan EngelterCompletedCervical Artery DissectionDenmark, Germany, Switzerland
-
The University of Texas Health Science Center,...RecruitingACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy (ACUTE-B)Distal Aortic Dissection | Dissection, Aortic Acute | Acute Type B Aortic Dissection (Uncomplicated)United States
-
Braile Biomedica Ind. Com. e Repr. Ltda.RecruitingThoracic Aortic DissectionBrazil
-
Assiut UniversityRecruitingAortic Root Aneurysm | Aortic Root DissectionEgypt
-
The University of Texas Health Science Center,...Washington University School of Medicine; University of Michigan; John Ritter...Active, not recruiting
-
Xijing HospitalChanghai HospitalCompletedAorta Thoracic Ascending Dissection | Dissection of Descending AortaChina
-
University of Milano BicoccaCompletedAxilla Node DissectionItaly
-
Petrovsky National Research Centre of SurgeryRecruitingThoracic Aortic Aneurysm | Thoracic Aortic Dissection | Cardiac Valve Disease | Aortic Aneurysm and DissectionRussian Federation
Clinical Trials on magnetic resonance imaging
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
University of California, San FranciscoTerminatedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
University of MichiganPhilips Healthcare; General ElectricCompleted
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterActive, not recruitingProstate Adenocarcinoma | Prostate CarcinomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMalignant Central Nervous System NeoplasmUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityRecruitingIntracranial NeoplasmUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Healthy SubjectUnited States
-
Stanford UniversityTerminatedLaryngeal Neoplasms | Head and Neck Cancers | Larynx CancerUnited States